WESCO (NYSE: WCC) EVP exercises rights and sells common stock
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
WESCO International EVP & CHRO Christine Ann Wolf exercised stock appreciation rights into 5,231 shares of common stock at a conversion price of $48.32 per share. These rights vested in three equal annual installments beginning on the first anniversary of the February 13, 2020 grant date.
On the same day, she disposed of 897 shares of common stock to the issuer, and 1,896 shares were withheld at $281.84 per share to cover the exercise price or tax liability. She also completed an open-market sale of 844 shares at $287.60 per share.
After these transactions, Wolf’s direct ownership stood at 32,004.5363 shares of WESCO common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 844 shares ($242,734)
Net Sell
5 txns
Insider
Wolf Christine Ann
Role
EVP & CHRO
Sold
844 shs ($243K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Appreciation Rights | 5,231 | $0.00 | -- |
| Exercise | Common Stock | 5,231 | $48.32 | $253K |
| Disposition | Common Stock | 897 | $281.84 | $253K |
| Tax Withholding | Common Stock | 1,896 | $281.84 | $534K |
| Sale | Common Stock | 844 | $287.60 | $243K |
Holdings After Transaction:
Stock Appreciation Rights — 0 shares (Direct);
Common Stock — 35,641.536 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What did WESCO (WCC) executive Christine Ann Wolf report in this Form 4?
Christine Ann Wolf reported exercising stock appreciation rights into 5,231 WESCO common shares, then completing several related share dispositions, including tax withholding and an open-market sale, leaving her with 32,004.5363 directly owned shares after the transactions.
What is the vesting schedule of the WESCO (WCC) stock appreciation rights exercised?
The stock appreciation rights exercised by Christine Ann Wolf became exercisable in three equal annual installments. This vesting schedule began on the first anniversary of the original February 13, 2020 grant date, according to the footnote disclosure in the Form 4.